Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 29 studies | 39% ± 16% | |
vein endothelial cell | 14 studies | 54% ± 22% | |
capillary endothelial cell | 11 studies | 53% ± 14% | |
endothelial cell of vascular tree | 9 studies | 33% ± 14% | |
endothelial cell of artery | 8 studies | 42% ± 8% | |
glomerular endothelial cell | 4 studies | 65% ± 5% | |
endocardial cell | 3 studies | 39% ± 11% |
Insufficient scRNA-seq data for expression of SLCO2A1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 8102.79 | 245 / 245 | 97% | 39.06 | 487 / 502 |
thymus | 100% | 20340.56 | 653 / 653 | 97% | 78.45 | 586 / 605 |
kidney | 100% | 9128.53 | 89 / 89 | 92% | 79.12 | 831 / 901 |
pancreas | 96% | 2375.48 | 314 / 328 | 95% | 47.17 | 169 / 178 |
esophagus | 98% | 3603.49 | 1420 / 1445 | 83% | 31.00 | 152 / 183 |
lung | 100% | 26671.45 | 578 / 578 | 81% | 34.06 | 937 / 1155 |
breast | 98% | 3876.20 | 448 / 459 | 80% | 18.98 | 898 / 1118 |
stomach | 98% | 3824.63 | 353 / 359 | 76% | 25.25 | 218 / 286 |
adrenal gland | 100% | 8165.38 | 258 / 258 | 73% | 29.59 | 168 / 230 |
intestine | 95% | 4502.00 | 922 / 966 | 75% | 17.86 | 393 / 527 |
bladder | 100% | 3777.81 | 21 / 21 | 65% | 16.11 | 330 / 504 |
uterus | 99% | 8420.46 | 169 / 170 | 59% | 18.83 | 273 / 459 |
skin | 68% | 1723.63 | 1229 / 1809 | 48% | 9.46 | 227 / 472 |
spleen | 99% | 5037.68 | 238 / 241 | 0% | 0 | 0 / 0 |
adipose | 90% | 4166.35 | 1078 / 1204 | 0% | 0 | 0 / 0 |
heart | 84% | 3034.29 | 722 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 78% | 2945.68 | 1046 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 78% | 32.13 | 35 / 45 |
ovary | 26% | 778.65 | 47 / 180 | 40% | 7.57 | 174 / 430 |
lymph node | 0% | 0 | 0 / 0 | 38% | 5.19 | 11 / 29 |
liver | 3% | 33.00 | 6 / 226 | 34% | 5.77 | 138 / 406 |
brain | 1% | 23.99 | 37 / 2642 | 31% | 4.81 | 222 / 705 |
eye | 0% | 0 | 0 / 0 | 6% | 0.76 | 5 / 80 |
muscle | 3% | 38.48 | 23 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 2.91 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043252 | Biological process | sodium-independent organic anion transport |
GO_0015732 | Biological process | prostaglandin transport |
GO_0055085 | Biological process | transmembrane transport |
GO_0006869 | Biological process | lipid transport |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0005764 | Cellular component | lysosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0009925 | Cellular component | basal plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005319 | Molecular function | lipid transporter activity |
GO_0015132 | Molecular function | prostaglandin transmembrane transporter activity |
GO_0015347 | Molecular function | sodium-independent organic anion transmembrane transporter activity |
Gene name | SLCO2A1 |
Protein name | Solute carrier organic anion transporter family member 2A1 (SLCO2A1) (OATP2A1) (PHOAR2) (Prostaglandin transporter) (PGT) (Solute carrier family 21 member 2) (SLC21A2) Solute carrier organic anion transporter family member |
Synonyms | SLC21A2 OATP2A1 |
Description | FUNCTION: Mediates the transport of prostaglandins (PGs, mainly PGE2, PGE1, PGE3, PGF2alpha, PGD2, PGH2) and thromboxanes (thromboxane B2) across the cell membrane . PGs and thromboxanes play fundamental roles in diverse functions such as intraocular pressure, gastric acid secretion, renal salt and water transport, vascular tone, and fever . Plays a role in the clearance of PGs from the circulation through cellular uptake, which allows cytoplasmic oxidation and PG signal termination . PG uptake is dependent upon membrane potential and involves exchange of a monovalent anionic substrate (PGs exist physiologically as an anionic monovalent form) with a stoichiometry of 1:1 for divalent anions or of 1:2 for monovalent anions . Uses lactate, generated by glycolysis, as a counter-substrate to mediate PGE2 influx and efflux . Under nonglycolytic conditions, metabolites other than lactate might serve as counter-substrates . Although the mechanism is not clear, this transporter can function in bidirectional mode . When apically expressed in epithelial cells, it facilitates transcellular transport (also called vectorial release), extracting PG from the apical medium and facilitating transport across the cell toward the basolateral side, whereupon the PG exits the cell by simple diffusion (By similarity). In the renal collecting duct, regulates renal Na+ balance by removing PGE2 from apical medium (PGE2 EP4 receptor is likely localized to the luminal/apical membrane and stimulates Na+ resorption) and transporting it toward the basolateral membrane (where PGE2 EP1 and EP3 receptors inhibit Na+ resorption) (By similarity). Plays a role in endometrium during decidualization, increasing uptake of PGs by decidual cells . Involved in critical events for ovulation . Regulates extracellular PGE2 concentration for follicular development in the ovaries (By similarity). Expressed intracellularly, may contribute to vesicular uptake of newly synthesized intracellular PGs, thereby facilitating exocytotic secretion of PGs without being metabolized (By similarity). Essential core component of the major type of large-conductance anion channel, Maxi-Cl, which plays essential roles in inorganic anion transport, cell volume regulation and release of ATP and glutamate not only in physiological processes but also in pathological processes (By similarity). May contribute to regulate the transport of organic compounds in testis across the blood-testis-barrier (Probable). . |
Accessions | E7EU40 F8W9W8 ENST00000310926.11 ENST00000493729.5 Q92959 ENST00000481359.3 |